Case Management Dyad
- Conditions
- HIVPre-exposure ProphylaxisCase Management
- Registration Number
- NCT06162897
- Lead Sponsor
- University of Chicago
- Brief Summary
The overall goal of this study is to test whether dyadic and focused case management will (1) improve financial wellbeing, (2) improve access to food, (3) increase linkage and retention rates for individuals living with HIV or those taking PrEP (PrEP persistence), and (4) increase the proportion of individuals living with HIV who are virally suppressed (viral suppression) when compared to routine Ryan White Non-Medical Case Management.
- Detailed Description
The purpose of this research is to test the impact of dyadic, focused case management on financial well-being, access to food, linkage to and retention in care outcomes for individuals living with or vulnerable to HIV. The study population is men who have sex with men (MSM) or same-sex attraction, gender-diverse persons, and cis-gender women living with or at increased vulnerability to HIV.
The study team will be testing the hypotheses that dyadic case management that is focused on financial wellness, will have better outcomes for folks living with or vulnerable to HIV. Analyses will be used to assess the efficacy of the intervention as an emerging practice.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 180
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Financial wellbeing 18 months Proportion of subjects who report improved financial wellbeing (e.g. consistent income, ability to pay bills).
Food Security 18 months Proportion of individuals who report improved access to food (e.g. fewer gaps in access to food, reduced concern about access to food).
- Secondary Outcome Measures
Name Time Method PrEP Persistence 18 months Proportion of individuals who have engaged in PrEP care regularly (beyond 6 months).
Viral Suppression 18 months Proportion of individuals who have a viral load below 200 copies/mL
Trial Locations
- Locations (1)
University of Chicago
🇺🇸Chicago, Illinois, United States
University of Chicago🇺🇸Chicago, Illinois, United StatesRebecca Eavou, AMContact231-357-5995reavou@bsd.uchicago.eduJohn A Schneider, MD, MPHPrincipal InvestigatorAlida Bouris, PhDSub Investigator